Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

III. Medizinische Klinik und Poliklinik

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10



Singh, Shuchi Agrawal; Bagri, Jaana; Giotopoulos, George et al.

HOXA9 Nucleates a Repressive Chromatin Complex with Nuclear Matrix-Associated Protein- Safb to Maintain Acute Myeloid Leukemia

BLOOD. Bd. 140. 2022


Beyer, Mandy; Henninger, Sven J.; Haehnel, Patricia S. et al.

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells

CELL CHEMICAL BIOLOGY. Bd. 29. H. 3. 2022 S. 398-+


Dreger, Peter; Holtick, Udo; Subklewe, Marion et al.

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

BONE MARROW TRANSPLANTATION. 2022


Gobel, Sebastian; Hobohm, Lukas; Desuki, Alexander et al.

Impact of cardiac amyloidosis on outcomes of patients hospitalized with heart failure

EUROPEAN JOURNAL OF INTERNAL MEDICINE. Bd. 102. 2022 S. 88-96


Vogelmeier, Claus F.; Worth, Heinrich; Buhl, Roland et al.

Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study

RESPIRATORY RESEARCH. Bd. 23. H. 1. 2022


Nowakowski, Grzegorz S.; Yoon, Dok Hyun; Peters, Anthea et al.

Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study

CLINICAL CANCER RESEARCH. Bd. 28. H. 18. 2022 S. 4003-4017


Platzbecker, Uwe; Goetze, Katharina S.; Kiewe, Philipp et al.

Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study

JOURNAL OF CLINICAL ONCOLOGY. Bd. 40. H. 33. 2022 S. 3800-+